Justin Stebbing

Justin Stebbing is a highly experienced medical professional with a robust background in oncology, drug development, and clinical strategy. Currently serving as a Board Member at Portage Biotech Inc. and on the Board of Directors for etiraRx, Justin Stebbing also holds executive roles including Senior VP Clinical Strategy and Innovation at Graviton Bioscience, Scientific Advisor positions at Sable Bio and Clinical Ink, and Chair of the Scientific Advisory Board at Zephyr AI. With a strong focus on utilizing advanced technology and innovative approaches, Justin Stebbing contributes to companies working on drug safety, longevity science, and cancer treatments. Justin Stebbing's educational credentials include multiple degrees from prestigious institutions such as the University of Oxford and The Johns Hopkins University, reflecting a profound expertise in medicine and immunology. Additionally, Justin Stebbing dedicates time as a Listening Volunteer at The Listening Place, providing support to individuals in distress.